Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment

• 收藏
• 分享

专利权人:

IgNova GmbH;Julius-Maximilians-Universitat Wurzburg

发明人:

Sprotte, Gunter,Waaga-Gasser, Ana Maria

申请号：

AU2016249856

公开号：

AU2016249856A1

申请日:

2016.04.14

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

The present invention relates to the biomarkers for predicting the clinical response to anti-LPS immunoglobulin treatments in patients in need thereof. In particular, the invention provides methods for predicting the clinical response to an anti-LPS immunoglobulin treatment in a patient in need thereof, said method comprising the steps of evaluating the expression of a predictive biomarker selected from the group consisting of CD14, CD68, TLR4, TLR7, IL6, IL8, IL10, IFN-alpha, IGF1, CXCL1, CXCL9, CXCL10, RAGE, GDNF, BCHE, and combination thereof, in said patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/